4D Molecular Therapeutics, Inc. Share Price
Stocks
FDMT
US35104E1001
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
17:34:10 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 12.76 USD | -1.31% |
|
+8.02% | +70.67% |
| 10-21 | 4D Molecular Therapeutics, Inc. - Analyst/Investor Day | |
| 10-07 | 4D Molecular Therapeutics Insider Sold Shares Worth $753,937, According to a Recent SEC Filing | MT |
| Market Cap | 714M 641M 593M 537M 1B 68.03B 1.01B 7.08B 2.82B 35.6B 2.68B 2.62B 113B | P/E 2026 * |
-3.12x | P/E 2027 * | -3.23x |
|---|---|---|---|---|---|
| Enterprise Value | 519M 466M 431M 390M 729M 49.44B 737M 5.15B 2.05B 25.87B 1.95B 1.91B 82.14B | EV / Sales 2026 * |
39.2x | EV / Sales 2027 * | 18.4x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FDMT | Delayed | |
CBOE
| FDMT | Real-time |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | -0.62% | ||
| 1 week | +8.86% | ||
| Current month | -9.85% | ||
| 1 month | -10.97% | ||
| 3 months | +34.24% | ||
| 6 months | +46.42% | ||
| Current year | +72.00% |
| 1 week | 10.62 |  | 13.46 |
| 1 month | 10.62 | | 14.83 |
| Current year | 6.96 | | 16.93 |
| 1 year | 6.96 | | 16.93 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 31/03/2018 |
David Kirn
CEO | Chief Executive Officer | 64 | 11/09/2013 |
Kristian Humer
DFI | Director of Finance/CFO | 51 | 16/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 11/09/2013 |
Charles Theuer
BRD | Director/Board Member | 62 | 30/11/2015 |
Jacob Chacko
BRD | Director/Board Member | 47 | 28/02/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/10/26 | Sell | Founder | -58,333 | 0.1056% | ||
| 16/09/26 | Exercice | Compliance Officer | 4,905 | 0.0089% | ||
| 14/09/26 | Sell | Founder | -58,333 | 0.1056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | +8.86% | +13.06% | +21.35% | 714M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.17% | -0.46% | +27.19% | +56.38% | 45.99B | |
| -0.78% | -2.89% | +17.90% | +98.93% | 42.45B | |
| +0.45% | +1.10% | +227.04% | +934.06% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.42% | +3.69% | +48.54% | +149.12% | 39.33B | |
| Weighted average by Cap. | -0.13% | +3.13% | +49.50% | +160.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26M 11.89M 11M 9.96M 18.61M 1.26B 18.83M 131M 52.37M 661M 49.74M 48.69M 2.1B | 20.63M 18.51M 17.12M 15.5M 28.96M 1.97B 29.31M 205M 81.51M 1.03B 77.43M 75.79M 3.26B |
| Net income | -289M -259M -239M -217M -405M -27.49B -410M -2.86B -1.14B -14.38B -1.08B -1.06B -45.66B | -316M -284M -262M -238M -444M -30.12B -449M -3.14B -1.25B -15.76B -1.19B -1.16B -50.03B |
| Net Debt | -195M -175M -162M -147M -274M -18.59B -277M -1.94B -771M -9.73B -732M -717M -30.88B | -334M -300M -277M -251M -469M -31.82B -475M -3.31B -1.32B -16.65B -1.25B -1.23B -52.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$12.81 | -0.93% | 249,955 |
| 28/10/26 | US$12.93 | +8.11% | 1,189,801 |
| 27/10/26 | US$11.96 | +8.43% | 1,134,654 |
| 26/10/26 | US$11.03 | +2.13% | 1,084,578 |
| 23/10/26 | US$10.80 | -8.86% | 996,140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
